Alberta Pharmaceutical Strategy phase two : brand name drugs

Description

In December 2008, Alberta Health and Wellness announced the Alberta Pharmaceutical Strategy to help make drug coverage more accessible, sustainable and affordable for all Albertans. The strategy included two phases. The second phase, announced in October 2009, focuses on generic drug prices and expanding the roles of pharmacists. This fact sheet focuses on how brand name drugs will be approached in this second phase of the strategy.

Updated

October 1, 2009

Resources

Alberta Pharmaceutical Strategy phase two : brand name drugs

More information Download
Downloads: 12

Title and publication information

Type

Fact Sheet

Extent

2 pages

Frequency

Once

Publisher / Creator Information

Creator

Publisher

Health and Wellness (1999-2013)

Place of Publication

Edmonton

Subject Information

Topic

Health and Wellness

Spatial Coverage

Alberta

Resource Dates

Date Created

2009-10-01

Date Added

2017-09-27T21:03:25.133831

Date Modified

2009-10-01

Date Issued

2009-10-01

Audience information

General Public

Language

English (Canadian)

Identifiers

Usage / Licence

Licence

Open Government Licence - Alberta

Contact

Available Fields

title | Title

Alberta Pharmaceutical Strategy phase two : brand name drugs

name | URL

alberta-pharmaceutical-strategy-phase-two-brand-name-drugs

owner_org | Publisher
```
be4cf96c-250a-4312-b10b-9c63c9c4db98
```
alternatetitle1 | Alternative Title
alternatetitle2 | Alternative Title
alternatetitle3 | Alternative Title
seriestitle | Series Title
seriestitle2 | Series Title
seriestitle3 | Series Title

notes | Description

pubtype | Type
```
Fact Sheet
```
creator | Creator
contributor | Contributor
contributor2 | Contributor
contributor3 | Contributor
contributor4 | Contributor
contributor5 | Contributor
contributor6 | Contributor
contact | Contact Name
email | Contact Email
contactother | Contact Other
placeofpub | Place of Publication
```
Edmonton
```
identifier-ISBN-print | ISBN (print)
identifier-ISBN-pdf | ISBN (pdf)
identifier-ISBN-html | ISBN (html)
identifier-ISBN-cdrom | ISBN (CD-ROM)
identifier-ISBN-dvd | ISBN (DVD)
identifier-ISSN-print | ISSN (print)
identifier-ISSN-online | ISSN (online)
identifier-AGDEX-number | AGDEX number
identifier-ALIS-catno | ALIS catalogue number
identifier-NEOS-catkey | NEOS catalogue key
identifier-local | Local Identifier
published_date, | Publish on this future date.
review_date | Review Date
createdate | Date Created
```
  2009-10-01
```
issuedate | Date Issued
```
  2009-10-01
```
date_modified | Date Modified
```
  2009-10-01
```
updatefrequency | Frequency
```
Once
```
topic | Topic
```
Health and Wellness
```
tag_string | Tags
subject | Subject (LCSH)
subject2 | Subject (LCSH)
subject3 | Subject (LCSH)
subject4 | Subject (LCSH)
subject5 | Subject (LCSH)
subject6 | Subject (LCSH)
time_coverage_from | Start Date
time_coverage_to | End Date
spatialcoverage | Spatial Coverage
```
Alberta
```
spatialcoverage2 | Spatial Coverage
spatialcoverage3 | Spatial Coverage
audience | Audience
```
General Public
```
Extent | Extent
```
2 pages
```
Extent2 | Extent
Extent3 | Extent
replacedby_title | Is Replaced By - Title
replacedby_uri | URI
replaces_title | Replaces - Title
replaces_uri | URI
hastranslation_title | Has Translation - Title
hastranslation_uri | URI
istranslation_title | Is Translation Of
istranslation_uri | URI
archivedate | Date Archived
usageconsiderations | Usage Considerations
language | Language
```
English (Canadian)
```
license_id | Licence
```
Open Government Licence - Alberta
```
sensitivity | Sensitivity
```
Unrestricted
```

Pkg Data

{'Extent': '2 pages', 'Extent2': '', 'Extent3': '', 'alternatetitle1': '', 'alternatetitle2': '', 'alternatetitle3': '', 'audience': ['General Public'], 'author': None, 'author_email': None, 'contact': '', 'contactother': '', 'contributor': '', 'contributor2': '', 'contributor3': '', 'contributor4': '', 'contributor5': '', 'contributor6': '', 'createdate': '2009-10-01', 'creator': ['Health and Wellness (1999-2013)'], 'creator_user_id': '0f4bccb5-8098-4f7c-928b-203dd4d3f163', 'date_modified': '2009-10-01', 'email': '', 'hastranslation_title': '', 'hastranslation_uri': '', 'id': '8544973d-ec58-4032-9d3a-df73c0c75170', 'identifier-AGDEX-number': '', 'identifier-ALIS-catno': '', 'identifier-ISBN-cdrom': '', 'identifier-ISBN-dvd': '', 'identifier-ISBN-html': '', 'identifier-ISBN-pdf': '', 'identifier-ISBN-print': '', 'identifier-ISSN-online': '', 'identifier-ISSN-print': '', 'identifier-NEOS-catkey': '', 'identifier-local': '', 'isopen': True, 'issuedate': '2009-10-01 00:00:00', 'istranslation_title': '', 'istranslation_uri': '', 'language': ['en-CA [default]'], 'license_id': 'OGLA', 'license_title': 'Open Government Licence - Alberta', 'license_url': 'https://open.alberta.ca/licence', 'maintainer': None, 'maintainer_email': None, 'metadata_created': '2017-09-27T21:03:25.133831', 'metadata_modified': '2022-03-09T20:17:53.525160', 'name': 'alberta-pharmaceutical-strategy-phase-two-brand-name-drugs', 'notes': 'In December 2008, Alberta Health and Wellness announced the Alberta Pharmaceutical Strategy to help make drug coverage more accessible, sustainable and affordable for all Albertans. The strategy included two phases. The second phase, announced in October 2009, focuses on generic drug prices and expanding the roles of pharmacists. This fact sheet focuses on how brand name drugs will be approached in this second phase of the strategy.', 'num_resources': 1, 'num_tags': 5, 'organization': {'id': 'be4cf96c-250a-4312-b10b-9c63c9c4db98', 'name': 'healthandwellness1999-2013', 'title': 'Health and Wellness (1999-2013)', 'type': 'organization', 'description': '', 'image_url': '', 'created': '2015-05-13T08:55:56.193751', 'is_organization': True, 'approval_status': 'approved', 'state': 'active'}, 'owner_org': 'be4cf96c-250a-4312-b10b-9c63c9c4db98', 'placeofpub': 'Edmonton', 'private': False, 'pubtype': ['Fact Sheet'], 'replacedby_title': '', 'replacedby_uri': '', 'replaces_title': '', 'replaces_uri': '', 'sensitivity': 'unrestricted', 'seriestitle': '', 'seriestitle2': '', 'seriestitle3': '', 'spatialcoverage': 'Alberta', 'spatialcoverage2': '', 'spatialcoverage3': '', 'state': 'active', 'subject': '', 'subject2': '', 'subject3': '', 'subject4': '', 'subject5': '', 'subject6': '', 'title': 'Alberta Pharmaceutical Strategy phase two : brand name drugs', 'topic': ['Health and Wellness'], 'type': 'publications', 'updatefrequency': 'Once', 'url': None, 'usageconsiderations': '', 'version': None, 'resources': [{'cache_last_updated': None, 'cache_url': None, 'created': '2017-09-27T15:03:35.795025', 'datastore_active': False, 'description': '', 'format': 'PDF', 'hash': '', 'id': '93adced9-7671-4f87-8625-2897dba2b1c8', 'last_modified': None, 'metadata_modified': '2017-09-27T15:03:35.795025', 'mimetype': 'application/pdf', 'mimetype_inner': None, 'name': 'Alberta Pharmaceutical Strategy phase two : brand name drugs', 'package_id': '8544973d-ec58-4032-9d3a-df73c0c75170', 'position': 0, 'resource_type': None, 'size': None, 'state': 'active', 'url': 'https://open.alberta.ca/dataset/8544973d-ec58-4032-9d3a-df73c0c75170/resource/93adced9-7671-4f87-8625-2897dba2b1c8/download/pharma-strategy-2-brand-drugs.pdf', 'url_type': 'upload', 'tracking_summary': {'total': 12, 'recent': 12}, 'has_views': False}], 'tags': [{'display_name': 'drug insurance', 'id': '02345bcd-4e49-43b3-aa4d-4c2b28bce61b', 'name': 'drug insurance', 'state': 'active', 'vocabulary_id': None}, {'display_name': 'drug plans', 'id': 'b1dff079-d961-4f1f-883b-405f11c6e4a4', 'name': 'drug plans', 'state': 'active', 'vocabulary_id': None}, {'display_name': 'health care system', 'id': '98ee4b98-9d8c-499c-8b40-348635ca5993', 'name': 'health care system', 'state': 'active', 'vocabulary_id': None}, {'display_name': 'pharmaceuticals', 'id': 'cc919334-a009-4ac2-a246-a4a7ffa51c22', 'name': 'pharmaceuticals', 'state': 'active', 'vocabulary_id': None}, {'display_name': 'prescription drugs', 'id': '962b2b0c-fa82-4967-b625-4ca357dbf2a7', 'name': 'prescription drugs', 'state': 'active', 'vocabulary_id': None}], 'groups': [], 'relationships_as_subject': [], 'relationships_as_object': [], 'tracking_summary': {'total': 201, 'recent': 201}, 'related_list': []}

Alberta Pharmaceutical Strategy phase two : brand name drugs

Description

Updated

Tags

Resources